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Introduction: Adipose tissue-derived stromal cells (ADSCs) are abundant and easy to obtain, but the diversity of
differentiation potential from different locations may vary with the developmental origin of their mesenchymal
compartment. We therefore aim to compare the myogenic differentiation and reparative activity of ADSCs derived
from the pericardial tissue to ADSCs of subcutaneous origin.
Methods: Pericardial and inguinal adipose tissues from Wistar rats were surgically obtained, and the stromal
fraction was isolated after enzymatic digestion. The phenotypic epitopes of the resultant two types of ADSCs were
analyzed with flow cytometry, and the expression of transcriptional factors was analyzed with immunostaining.
Furthermore, their potential toward adipogenic, osteogenic, and myogenic differentiation also was compared.
Finally, the reparative activity and the resultant functional benefits were examined by allograft transplantation into
an infarcted model in rats.
Results: ADSCs from two adipose sources showed identical morphology and growth curve at the initial stage, but
inguinal ADSCs (ingADSCs) sustained significantly vigorous growth after 25 days of cultivation. Although both
ADSCs shared similar immunophenotypes, the pericardial ADSCs (periADSC) intrinsically exhibited partial expression
of transcription factors for cardiogenesis (such as GATA-4, Isl-1, Nkx 2.5, and MEF-2c) and more-efficient myogenic
differentiation, but less competent for adipogenic and osteogenic differentiation. After in vivo transplantation,
periADSCs exhibited significantly vigorous reparative activity evidenced by thickening of ventricular wall and
pronounced vasculogenesis and myogenesis, although the majority of prelabeled cells disappeared 28 days after
transplantation. The structural repair also translated into functional benefits of hearts after infarction.
Conclusions: Although two sources of ADSCs are phenotypically identical, pericADSCs constituted intrinsic
properties toward myogenesis and vasculogenesis, and thus provided more potent reparative effects after
transplantation; therefore, they represent an attractive candidate cell donor for cardiac therapy.Introduction
Adipose tissue is now recognized as an abundant, easily
accessible source for obtaining regenerative stromal/me-
senchymal stem cells (MSCs) [1]. Adipose-derived stem
cells (ADSCs) are a highly proliferative cell population
that has the potential to differentiate toward multiple
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ADSCs have been recently made use of tissue engineer-
ing and stem cell-based therapy in both experimental
settings and clinic trails [3,4].
Although it has been assumed that all MSCs from
different adipose tissues are phenotypically similar and
homogeneous, this notion ignores important biologic di-
versity among various ADSCs [5]. The cell source-related
heterogeneity may not only be related to cell proliferation,
clonogenicity, and the potential to differentiate, but also
may greatly affect the survivability and behavior after be-
ing transplanted into the hostile environment of ischemia,
inflammation, proapoptotic factors, and scarring fromtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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[6] systematically compared the cellular epitopes, cytokine-
secretion profiles, and immunomodulatory properties
of MSCs from five different origins of cardiac patients
and suggested that ADSCs from different locations have
both distinct characteristics and different reparative prop-
erties [6]. This result also raises the question whether the
ADSCs from different sources share a similar potential to-
ward myogenic differentiation, a key issue for cardiac
regeneration.
In the view of developmental biology, adipose tissue
originates from mesoderm, but the tissue stromal cells
are highly homologous with the organs in which they
reside, leading to biologic variations, including the differ-
entiation potency toward certain cell types [7]. In heart,
the epicardial and pericardial ADSCs were formed dur-
ing embryonic heart development from the neural crest
and the pro-epicardial organ (a cluster of cells located
dorsal and adjacent to the looped heart tube) that mi-
grated onto the surface layer of the heart tube to form
the second heart field, including the coronary system,
epicardium, and pericardium, as well as subepicardial
myocardium [8]. The pericardium is a continuous layer
of parietal epicardium and consists of a thin fibrous
layer, nerves and vascular network, and adipose mass.
The pericardial tissue, analogous to the epicardium, has
been recently shown to comprise a mesodermal origin of
mesenchymal cells, so-called formed cardiac colony-
forming-unit fibroblasts (cCFU-Fs) that give rise to all
mesodermal lineages, including smooth muscle, bone,
cartilage, adipose, endothelial, and heart muscle cells [9].
Therefore, we hypothesized that pericardial fat could
provide stromal stem cells with better cardiomyogenic
differentiation and reparative activity because of their
proximity to the heart. In the present study, we com-
pared the immunophenotypes and the differential effi-
ciency of pericardium-derived ADSCs with the ADSCs
from the extracardiac subcutaneous fat tissues that are
nowadays widely used in clinical trials [3]. Our results
showed that the pericardial ADSCs are more competent
for myogenic differentiation and yielded more-efficient
cardiac repair in vivo. Because pericardial fat tissue can
be surgically obtained, pericardial ADSCs represent an
attractive cell source for stem cell-based therapy for is-
chemic heart disease.Methods
Isolation and cultivation of ADSCs
All the experiments were approved by the Experimental
Animal Care and Use Committee at the Zhejiang Chinese
Medical University (SCXK Hu 2008–0016). The ADSCs
were isolated according to the modified protocol previ-
ously reported [3]. In brief, Wistar male rats with bodyweight of 200 to 300 g (n = 29) were killed by using CO2
suffocation followed by immersion with 75% ethanol for 3
minutes for the entire body disinfection. Under sterilized
conditions, rat chest and the lower abdomen were cut to
harvest inguinal and pericardial adipose tissues. The col-
lected adipose tissues were first cut into small pieces and
washed with PBS to remove adipose drops. Then the tis-
sue pieces were mixed with 10 ml of collagenase (0.4%,
Biochrom, Germany) and incubated at 37°C with gentle
rotation (20 rpm) for 20 minutes. The activity of the colla-
genase was neutralized with DMEM medium containing
30% FCS (HyClone, USA), and the cell suspension was
spun down at 1,000 rpm for 5 minutes. The supernatant
was then discarded, and the cell pellet was resuspended
with basic medium containing low-sugar DMEM and
supplemented with 30% FCS, penicillin (100 U/ml),
streptomycin (0.1 mg/ml), and glutamine (2 mM). The
isolated cells were inoculated in a density of 2 × 103/cm2
into a T25 culture flask and incubated at 37°C with 5%
CO2. Nonadherent cells were removed 12 hours after initial
plating by intensely washing the flask, and the resulting ad-
herent stromal vascular fraction was then termed adipose-
derived stromal cells (ADSCs). Both pericardial and inguinal
ADSCs were cultivated under the same conditions and har-
vested at subconfluence by using 0.05% trypsin-EDTA
(Sigma). Cell numbers were counted in a small aliquot on 5,
8, 11, 15, 25, 50, and 70 days, respectively, and the total cell
numbers were calculated for plotting cell-growth curves.
For genetic labeling of periADSCs with eGFP, sub-
confluent periADSCs were transfected with a lentiviral
vector derived from the HIV1-vector pGJ3-CSCGW, car-
rying eGFP under the control of the U3 promoter of
spleen focus-forming virus (SFFV). After infection, peri-
ADSCs were exhaustively washed (>10 times with PBS),
and the expression of eGFP was examined with fluores-
cence microscopy and qualified with flow cytometry.Characterization of the surface epitopes for the two
sources of ADSCs
For the characterization of the surface epitopes of the iso-
lated ADSCs, the cultured ADSCs were allowed to grow
up to 90% confluence and analyzed with fluorescence-
activated flow cytometry (n = 4 for periADSCs and
n =3 for ingADSCs, all first passage). The following
cell-surface epitopes were marked with anti-murine
antibodies: IgG1, CD29, CD31, CD34, CD44, CD45,
CD90 (Becton Dickinson, USA), and CD106 (Miltenyi
Biotec, Germany). Cells were incubated with anti-
bodies with a dilution of 1:100 to 200 for 30 minutes
at room temperature. After washing 3 times, we analyzed
about 1,000 labeled cells analyzed by using a FACScan
flow cytometer running CellQuest software (Becton
Dickinson, USA).
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For immunocytochemical analysis, the primary cells (first
passage) grown in chamber slides were fixed with 1%
paraformaldehyde and permeabilized with 0.25% Triton
for 30 minutes. After 1 hour of blocking in 5% nor-
mal goat serum (NGS), cells were incubated for 1 hour
with primary antibodies, including polyclonal anti-cTnT
(DAKO, Germany) 1:100 and polyclonal anti-GATA-4, isl-
1, Nkx-2.5, and MEF-2c 1:50 (Santa Cruz, USA). After
washing in 1% NGS-PBS buffer, we added secondary
TRTIC-conjugate antibody (goat IgG, Santa Cruz) and
incubated for 60 minutes. Nuclei were counterstained
with DAPI (DAKO), and the chamber slides were sealed
with Prolong Gold (Life Science, USA). All visualization
was digitalized by using phase-contrast microscopy
(Olympus BX61, Japan) with software (SIS F-View).Induction of myogenic, adipogenic, and osteogenic
differentiation
To induce ADSCs to adipogenic differentiation, both
periADSCs and ingADSCs at passage 2 were seeded
at a density of 2 × 104 cells/cm2 in basal medium.
After 24 hours, medium was switched to high-glucose
adipogenic induction medium (Gibco, life technolo-
gies, USA), supplemented with 10% FCS, 1% L-glut,
1% Pen-Strep, 1 μM dexamethasone, 1 μM indometh-
acin, 500 μM 3-isobutyl-1-methylxanthine (IBMX,
Sigma, USA), and 10 μg/ml human recombinant insu-
lin, as previously reported [1]. The culture medium
was changed twice a week, and induction was maintained
for 2 weeks before oil red staining was performed.
To promote osteogenic differentiation, the culture medium
was switched to osteogenic medium (Cyagen, China),
containing 10% FCS, 1% Pen-Strep, 1 μM dexamethasone),
50 μM ascorbate, and 10 μM β-glycerophosphate (Sigma,
USA) [1]. The culture medium was changed twice per week,
and induction was maintained for 2 weeks before alizarin
red staining was performed, as described later.
For the induction of ADSCs toward myogenic differ-
entiation, both periADSCs and ingADSCs were seeded
at a density of 3.1 × 103 cells per cm2 into eight-chamber
slides (Nunc, Thermo Scientific, USA) and cultured in
DMEM culture medium. As soon as subconfluence was
reached, cardiac differentiation of the ADSCs was in-
duced by changing the culture medium into DMEM
supplemented with only 5% FCS, 5% horse serum to-
gether, with 0.1 mM 5-azacytidine (Sigma) and 0.1 μM
dexamethasone (Sigma). Medium was changed every 3
days up to 2 weeks, until cultures were fixed and stained
for cardiac troponin T (cTnT) for assessment of cardio-
myogenic differentiation. Percentage was derived by
counting the number of cTnT-positive cell versus total
cell numbers (DAPI positive).In vivo allograft transplantation
To compare directly the regenerative properties of dif-
ferent sources of ADSCs, we injected the two types of
ADSCs into the rat heart after 60 minutes of ischemia,
as previously described [10]. In brief, male Wistar rats
(250 to 320 g; n = 16) were intubated and anesthetized
by mechanical ventilation with isoflurane (1.5% vol/vol;
Abbott) in 100% oxygen and placed in a supine position
with paws taped for ECG measurement. The chest was
then opened with a lateral cut along the left side of the
sternum. Ligation was done with a 6–0 polypropylene
suture with a tapered needle passed underneath the
LAD. The success of occlusion of the LAD was verified
visually under the microscope by the absence of blood
flow in the epicardium as well as significant elevations
of the S-T segment. The occlusion was maintained for
60 minutes until the suture was released. Rats were
randomized into two groups for periADSC (n = 5) or
ingADSC (n = 5; one died of ischemia due to ventricular
fibrillation) injection. Thereafter, two types of ADSCs at
the second passage (500,000 in 50 μl PBS) were injected
directly into a single spot at the middle of the infarcted
ventricular free wall by using a 500-μl insulin syringe.
Additionally, same amount of prelabeled periADSCs
were applied into the infarcted hearts (n = 6) for the
evaluation of the survival and integration of periADSCs
into the host myocardium. After injection, a tiny drop of
Trypan Blue (1 to 2 μl) was applied to mark the spot of
injection. After the animal recovered from the trans-
plantation procedure, the chest was closed with one
layer through the muscle and a second layer through the
skin. Animals then were weaned from ventilation and
placed in a warm and oxygen-enriched environment until
they fully recovered.
The survival of eGFP-periADSCs was analyzed in the
early phase (1 hour, n =3) and long-term (28 days, n =3)
by evaluation of GFP-positive cells in a total of 24 suc-
cessive sections of the hearts. For the comparison of
functional benefits 28 days after transplantation, the ani-
mals received either periADSCs (n = 5) or ingADSCs
(n = 4) were anesthetized by inhalation of isoflurane
(1.5% vol/vol) by using a home-made mask, and echo-
cardiography (Hewlett Packard Sonos 5500 equipped
with 15-MHz linear array probe, USA) was performed.
All data were stored, and parameters of cardiac function
were analyzed offline with customized software (Hewlett
Packard). Thereafter, rats were killed, and the hearts were
excised. After one washing in ice-cold PBS, the hearts
were carefully positioned and embedded in Tissure-Tek
(Leica, Germany) and snap-frozen in liquid nitrogen.
Cryosections were made until the site of injection was de-
fined (located about 5 mm from the apex of the heart).
The successive 8-μm sections were made and fixed with
paraformaldehyde for 30 minutes at room temperature.
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and eosin (H&E), Sirius Red, or indirect immunostaining
of cTnT as a cardiac marker or vWF for an endothelial
marker (see earlier). Photos were acquired by using a
fluorescence microscope (MX 61, Olympus) and recorded
by using a digital camera (FVreII and UC30; Olympus).
The wall thickness was derived from five measurements at
the site of injection that was marked with Trypan Blue in
three successive sections with interval of 0.5 mm. The wall
thickness and percentage of cardiomyocytes (cTnT posi-
tive) were analyzed in all animals (n = 5 in the periADSC
group and n = 4 in the ingADSC group) by using Cell-
Sence imaging analysis software. Vessel density (1 to 100
μm) was manually counted in a given area at the site of
injection.
Statistical analysis
Data are presented as mean ± standard deviation. A two-
sided, nonpaired t test was used to analyze the flow cy-
tometry and the cumulative doubling data. A Student t
test with a Welch correction was applied to compare the
differentiation capacities of ADSCs isolated from the dif-
ferent tissues. Differences were considered significant at
P < 0.05. The Prism software package (version 3.0) was
used for the statistical analysis.periADSCs




















Figure 1 Characterization of adipose-derived stromal cells (ADSCs) de
from pericardial (periADSCs) and inguinal adipose tissues (ingADSCs) were
analogous to fibroblasts (A). Both ADSCs exhibited a logarithmic growth in
periADSCs, and a significant difference was observed on day 25 (B, n = 3 inResults
Morphologic and immunophenotypical analysis
Both pericardial ADSCs (periADSCs) and inguinal ADSCs
(ingADSCs) were plastic adherent and, after 2 days of
cultivation, they showed microscopically identical morph-
ology with large spreading cells with a highly branched
shape and fibroblast-like appearance (Figure 1A). Both
ADSCs grew relatively fast, with population-doubling time
of 2.3 days under a culture condition of 30% FCS. Every 5
days when 90% confluence was reached, cells were pas-
saged, and total cell numbers were calculated. The growth
curve showed that both periADSCs and ingADSCs main-
tained initially exponential growth, but from 25 days on,
ingADSCs still remained in vigorous growth, whereas
periADSCs seemingly reached a platform (Figure 1B, n = 3
in each group).
Further to characterize whether the two sources of
ADSCs are different in surface epitopes, we analyzed
the expressions of surface antigens in both ADSCs by
using flow cytometry. Both periADSCs and ingADSCs
showed positive staining for mesenchymal stem cell mar-
kers (CD29, CD44, and CD90) and negative for hemato-
poietic markers (CD34 and CD45) and an endothelial
marker (CD31). Only a slight heterogeneous expres-
sion of CD106 was detected between two ADSCs (Table 1),ingADSCs 





rived from pericardial and inguinal adipose tissue. ADSCs both
adhesive and exhibited nondistinguishable spindle morphology that
the first 3 weeks; thereafter ingADSCs grew slightly faster than
each group). *P < 0.05; bar = 100 μm.
Table 1 Flow-cytometric analysis of the
immunophenotypes in two ADSC populations
periADSCs (n = 4) ingADSCs (n = 3)
CD 29 99.90 ± 1.2 99.89 ± 0.1
CD 31 1,12 ± 0 1.48 ± 0.1
CD 34 1.48 ± 1.2 0.68 ± 0.4
CD 44 99.78 ± 1.3 99.84 ± 1.8
CD 45 0.36 ± 0.2 0.43 ± 0.3
CD 90 99.35 ± 0.7 99.85 ± 0
CD 106 48.85 ± 13.2a 10.22 ± 8.5
IgG1 1.26 ± 0.8 0.40 ± 0.2






















Figure 2 Immunocytochemical comparison of cardiac factors. The per
GATA-4, Isl-1, Nkx-2.5, and MEF-2c, whereas the inguinal ADSCs (ingADSCs;
bar = 20 μm.
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ADSCs than in ingADSCs (48.85 ± 13.2% versus 10.22 ±
8.85%; P < 0.01; n = 4 and 3). Altogether, the immunophe-
notypical characterization indicated that both periADSCs
and ingADSCs shared mostly similar surface epitopes.
Expression of transcription factors for cardiomyogenesis
Because periADSCs are associated with the second heart-
field development, we further analyzed cardiac-related
transcriptional factor with immunostaining. Interest-
ingly, some cTnT-positive cells could already be ob-
served (2.8% ± 1%; n = 3) in the first passage of periADSCs
before induction to cardiac differentiation, which was
never seem in ingADSCs (Figure 2, n = 3).
The analysis of the expression of the myogenic trans-






periADSCs    ingADSCs
periADSCs    ingADSCs
periADSCs    ingADSCs
periADSCs    ingADSCs
periADSCs    ingADSCs
icardial ADSCs (periADSCs; n = 3) stained partially positive for cTnT,
n = 3) stained almost negative for these factors. **P < 0.01, and
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2.5, and MEF-2c exclusively in the periADSCs. Among
them, GATA-4 displayed the highest expression (65.7% ±
19%; n = 3), followed by medium expression of Isl-1 and
MEF-2c (22.3% ± 11%; n = 3 for and Isl-1, 32.3% ± 13%;
n = 3 for MEF-2c, respectively) and a low level of Nkx-2.5
(14.3% ± 2%; n = 3). By contrast, no expression was de-
tected for almost all the factors analyzed, except for a
weak expression of Isl-1 in the ingADSCs (3.7% ± 0.5%;
n = 3). These data suggest that the pericardium-derived
ADSCs intrinsically express cardiac factors and thus con-
stitute some biologic properties similar to cardiac proge-
nitor, whereas the ingADSCs of subcutaneous origin are
eventually absent.
Differentiation potentials
Because periADSCs showed transcriptional potentials for






























Figure 3 Comparison of differentiation potential of two sources of AD
morphology, but the pericardial ADSCs (periADSCs) formed spherical struct
cells in comparison with inguinal ADSCs (ingADSCs, n = 8 in each group). T
spherical structure. In contrast, periADSCs were less competent to adipoge
(P < 0.01; n = 5 in each group), as indicated by oil red and alizarin staining.of two types of ADSCs toward cardiac differentiation.
After pharmacologic induction for 7 days, both peri-
ADSCs and ingADSCs displayed an enlarged cellular
volume but identical morphology. However, significantly
more spherical structures analogous to cardiospheres
formed in periADSCs in comparison with ingADSCs
(32 ± 7 versus 7 ± 1; P < 0.01; n = 8 in each group; Figure 3).
Interestingly, multiple cTnT-expressing progenitors were
generated from inside the spheres (insert in Figure 3).
These cTnT+ progenitors were round but elongated after
having migrated out from the spheres. By quantification,
the total of the cTnT+ cells in periADSCs after induction
was significantly more than that in ingADSCs (32% ± 11%
versus 11% ± 5%; P < 0.01; n = 8 in each group), suggesting
that periADSCs are prone to cardiac differentiation at
given optimal conditions. Conversely, periADSCs were
less potent toward osteogenic (P < 0.01; n = 5 in each





periADSCs   ingADSCs
periADSCs   ingADSCs
periADSCs   ingADSCs
periADSCs   ingADSCs
SCs. After cardiac induction, both ADSCs showed enlarged
ures similar to cardiospheres and significantly more cTnT-expression
he inset shows the formation of cTnT-expressing cells within the
nic (P < 0.01; n = 5 in each group) and osteogenic differentiation
Bar = 100 μm.
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son with ingADSCs after 2-week induction (Figure 3).
In vivo comparison of regenerative activity
Given that periADSCs showed significant potentials for
myogenic differentiation, we performed allograft trans-
plantation of the two types of ADSCs into the infarcted
heart to compare their regenerative activity and func-
tional improvement in vivo. At 28 days after intramyo-
cardial injection, the ventricular wall at the site that
received periADSCs (Trypan blue marked) was signifi-
cantly thickened in comparison with the wall that re-
ceived ingADSCs injection (P < 0.01 in upper panel of
Figure 4, n = 5 and 4). Interestingly, the increased wall
consisted of many mature cardiomyocytes that stained
positive for cardiac cTnT, whereas the ingADSCs-injected
site showed significantly fewer cardiomyocytes, mainly lo-
cated at the endo- and subepicardial territories (middle
panel in Figure 4; n = 5 and 4).
Most important, the periADSCs-induced structural
repair was found to translate into functional amelior-






















Figure 4 In vivo comparison of regenerative activity and cardiac func
(periADSCs) and inguinal ADSCs (ingADSCs) were intramyocardially injected in
significant increase of the wall thickness at the site where periADSCs were inj
(upper panel, P < 0.01; n = 5 and 4). The site of periADSC injection comprised
by periADSCs injection (middle panel, P < 0.01; n = 5 and 4). Echocardiograph
anterior wall and improvement of ejection fraction (EF) in periADSCs-treated h
upper and 200 μm in middle panel.showed a restoration of the thickness and contractile mo-
tion of the infarcted ventricular wall and a significant im-
provement of cardiac ejection fraction (EF) in rats after
they were treated with periADSCs in comparison to those
after ingADSCs (lower panel in Figure 4 and Table 2; n = 5
and 4). Thus, this result suggests that periADSCs gener-
ated better regenerative effects in vivo characterized by
the robust formation of cardiomyocytes and thus enhance
structural repair, whereas ingADSCs exhibited only a
minor effect.
We further investigated whether the beneficial effects
were generated by direct conversion of periADSCs into
cardiomyocytes. In this context, periADSCs were genet-
ically labeled by eGFP lentiviral vectors and injected into
the infarcted myocardium, as described earlier. Before
transplantation, periADSCs showed 81% ± 5% (n = 3)
eGFP expression and 45% ± 12% (n = 3) cardiac reten-
tion 1 hour after transplantation (Figure 5A). However,
28 days after injection, only a few GFP-positive cells
were detected (<0.01%; Figure 5A, n = 3), although in
the meantime, a mass of cardiomyocytes formed at the
site of injection, suggesting an indirect effect of theDSCs 
**
periADSCs    ingADSCs
periADSCs    ingADSCs
*
*
periADSCs    ingADSCs
tion after treatment with two sources of ADSCs. Rat pericardial
to the infarcted heart, directly after injury. H&E staining demonstrated a
ected in comparison with that of ingADSCs 28 days after transplantation
significantly more cardiomyocytes, suggesting a cardiogenesis induced
ic analysis revealed a restoration of contractile activity in the infarcted
eart (P < 0.05, n = 5 and 4). **P < 0.01 and *P < 0.05. Bar = 2 mm in the
Table 2 Comparison of cardiac function in the infarcted
rats received two population of ADSC treatment
periADSCs (n = 5) ingADSCs (n = 4) P value
IVSd (cm) 0.18 ± 0.01 0.16 ± 0.02 0.142
LVIDd (cm) 0.71 ± 0.09 0.80 ± 0.06 0.123
LVPWd (cm) 0.26 ± 0.04 0.29 ± 0.04 0.306
IVSs (cm) 0.24 ± 0.03 0.19 ± 0.02 0.024a
LVIDs (cm) 0.51 ± 0.07 0.64 ± 0.10 0.08
LVPWs (cm) 0.43 ± 0.05 0.51 ± 0.04 0.037a
EDV (μl) 263.8 ± 41.2 344.3 ± 51.4 0.052
ESV (μl) 123.8 ± 38.2 208.5 ± 42.5 0.021a
FS (%) 20.1 ± 3.2 28.5 ± 4.5 0.025a
aP < 0.05 in comparison with ingADSCs.
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tors that contributed to cardiac regeneration after peri-
ADSCs transplantation.
In addition to striking myogenesis, periADSCs were
able to induce angiogenesis when injected into the in-
jured myocardium, as significantly more vWF-positive
(endothelial marker) vessel structures were found in the



















Figure 5 Cardiac engraftment of periADSCs and the induced vasculog
eGFP before injection (A, after trypsinization) and optimal cardiac retention
heart section (<0.01%; n = 3). Transplantation of periADSCs increased vessel d
proangiogenic effects by periADSCs, but did not alter collagen deposition (B,(upper panel in Figure 5B, n = 5 and 4). Conversely, the
reparative activity of periADSCs seems not to be related
to a reduction of cardiac fibrosis, as the collagen volume
fraction (CVF) in the hearts receiving either periADSCs
or ingADSCs injection showed a similar amount 28 days
after myocardial infarction (22.8% ± 8.0% versus 28.50% ±
10.0%, n = 5 and 4, lower panel in Figure 5B). Thus, peri-
ADSCs rendered structural repair of the injured heart
after myocardial ischemia and thus functional improve-
ment by enhancing local myogenesis and vasculogenesis
via indirect paracrine effects.
Discussion
In the present study, we compared the differentiation
potential and reparative properties of ADSCs derived
from pericardial fat in relation to subcutaneous fat from
the groin. Our data suggest that although both ADSCs
are phenotypically identical, periADSCs constitute a
vigorous potential toward myogenic differentiation by
endogenously expressing transcriptional factors for cardi-
ogenesis. Notably, transplantation of periADSCs into the
injured myocardium resulted in significant functional
improvement and structural repair by robust myogen-
esis and vasculogenesis. Therefore, pericardial fat-derivedDSCs 
periADSCs    ingADSCs
**
periADSCs    ingADSCs
ction (1 h) post-injection (28 d)
enesis. The prelabeled periADSCs showed a majority of expression
(45%; n = 3), but only rare eGFP-positive cells were detected in the
ensity at the site of injection in comparison with ingADSCs, indicating
n = 5 and 4). **P < 0.01 and bar = 50 μm in A and 200 μm in B.
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of ischemic heart disease.
In recent years, increasing evidence demonstrated that
multipotent stem cells derived from mature adipose tis-
sues are able to differentiate into osteocytes, chondro-
cytes, adipose cells, cardiomyocytes, and neural cells [3].
Because the adipose tissues are abundant and clinically
easy to obtain, they have been considered to be an ideal
source for obtaining donor cells in regenerative medicine
[11,12]. In those ongoing preclinical and clinical studies,
the ADSCs were mainly isolated from subcutaneous
liposuction [13], although visceral adipose tissues also
can serve as a source for generating ADSCs. Given that
the biology of subcutaneous adipose tissue differs from
that of visceral fat in terms of insulin resistance, lipome-
tabolism, and secretion patterns, the subpopulation of
the stromal fraction may also vary on where tissue stro-
mal cells are located [14,15]. For instance, cardiac MSCs
have been shown to present cardiovascular-associated
features and were more efficient for cardiac repair [16].
However, location-related diversity of ADSCs in terms of
differentiation potential and regenerative capacity has
not been well documented.
In the present study, we first compared the phonotypic
properties of two types of ADSCs from different sources
and found that the ADSCs of subcutaneous and visceral
origin display the same morphology and surface epitopes
that were undistinguishable with flow cytometry (Table 1).
Both periADSCs and ingADSCs express mesenchymal
markers, as previously reported [6,17], with only minor
heterogeneity of CD106 expression. CD106 is also known
as vascular cell adhesion molecule 1 (VCAM-1) and iden-
tifies a subpopulation of MSCs with unique immunomo-
dulatory properties [18]. Whether the more sub-fractions
of CD106 positive cells in the periADSCs attributed
to the in vivo regenerative activity needs to be further
characterized.
The striking finding in this study is that periADSCs
constitutively express of some key transcriptional factors
important for cardiomyogenesis, including GATA-4, Isl-1,
Nkx-2.5, and MEF-2c, whereas ingADSCs were fairly ab-
sent, indicating that the periADSCs hold a potent intrinsic
capability towards cardiac differentiation. This notion was
further supported by our inductive experiment, showing
the significant formation of cardiospherical structure and
the vigorous generation of cTnT-expressing cardiac pro-
genitors in comparison to ingADSCs. Although subcu-
taneous ADSCs have been well demonstrated to display
cardiac potential [1,2], the more efficient cardiac diffe-
rentiation of periADSCs may be related to their develop-
mental origin [16]. The epicardial and pericardial MSCs
developmentally initiated from the proepicardial cluster of
cells located dorsal and adjacent to the heart tube and mi-
grated onto the surface layer to form the second heartfield [19] and retained postnatally the ability to form car-
diac colony-forming-unit fibroblasts (cCFU-Fs) [9]. Thus,
the ADSCs isolated from the pericardial adipose tissue are
supposed to constitute some biologic properties similar to
cardiac progenitors that contributed to the homeostasis of
the heart [9].
The diversity of ADSCs from different locations has
been previously described, but their myogenic activity
has not been compared [6]. The unique feature of myo-
genic potency of periADSCs prompts us to investigate
further the regenerative capacity relevant to the use of
ADSCs for cardiovascular regeneration. In this context,
we injected the same amounts of two types of ADSCs
into the middle of the infarcted area and analyzed the
follow-up structural and functional repair.
Our results demonstrate that, in direct contrast to
ingADSCs, periADSCs were able to superiorly induce
significant myogenesis and angiogenesis restrictively at
the site of injection, but did not alter the infarct size
(data not shown) or collagen deposition (Figure 5B). The
structural and functional benefits after the transplan-
tation of periADSCs did not result from the direct con-
version of the ADSCs into the cardiac lineage, as nearly
all prelabeled eGFP-positive periADSCs disappeared 28
days after transplantation (Figure 5A), likely because of
apoptosis-mediated cell loss [20]. Regardless of the min-
imal engraftment in the host myocardium, periADSCs
exclusively triggered significant formation of cardio-
myocytes (Figure 4), whereas ingADSCs failed to do so,
suggesting a unique property of periADSCs on the myo-
genesis via an indirect action on endogenous cardiac
stem cells. The mechanistic interlink showing how peri-
ADSCs communicated with endogenous stem cells is
not clear, but may relate to apoptotic body-mediated ex-
change of genetic materials (that is, transcriptional fac-
tors) via horizontal gene transfer [21] and/or via indirect
paracrine-related proangiogenic and immunomodulatory
effects, as reported previously by Naftali-Shani et al. [6].
Therefore, those data underscore the definition of para-
crine factors and the underlying mechanism by which the
endogenous regeneration was evoked.
We are aware of several limitations in the present
experiments. First, the differences in adipogenesis and
osteogenesis of two types of ADSCs were compared only
in in vitro conditions and must be characterized further
in the in vivo condition as to cardiac transplantation.
Second, cardiac transplantation was made of a single in-
jection in the infarcted area, and in the future, multiple
spots of injection in the border zone may be needed to
maximize the functional benefits after myocardial injury.
Also, the comparison of cardiac function of two types of
ADSCs was analyzed only at the end point (28 days after
transplantation), whereas the starting baseline data is
still missing. Therefore, further study must assess cardiac
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ics of functional recovery after ADSC-based therapy.
Finally, de novo formation of cardiomyocytes must be
experimentally proved.Conclusions
In summary, our results showed that both ADSCs
showed similar morphology and cell-surface epitopes,
but periADSCs exhibited potent differentiation toward
cardiomyocytes, which could be explained by endogenous
expression of important transcriptional factors in peri-
ADSCs for cardiomyogenesis. Notably, periADSCs in-
duced significant structural repair in the injured heart in
comparison with the subcutaneous donors that have been
widely used in the present clinical trials. Because pericar-
dial adipose tissue can be obtained easily, periADSCs may
represent attractive donor cells in cardiac regenerative
medicine.
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